Berlin Symposium on Radiotherapy of Ocular Diseases

2015 ◽  
pp. 1-7
Author(s):  
N. Willich
Keyword(s):  
Ocular Diseases

Ocular Diseases at the Medical-Surgical Clinic Ophthalmology of Brazzaville

2019 ◽  
Vol 02 (03) ◽  
Author(s):  
Nganga Ngabou Charles Géraud Fredy ◽  
Makita Chantal ◽  
Onka Vissimy ◽  
Messe Ambia Koulimaya Reinette ◽  
Diatewa Benedicte ◽  
...  
Keyword(s):  
Ocular Diseases ◽  
Surgical Clinic

Prevalence of ocular diseases in patients with pulmonary tuberculosis and HIV infection

2016 ◽  
Vol 64 (6) ◽  
pp. 29-31
Author(s):  
A. Zborovskaia ◽  
◽  
N. Konovalova ◽  
T. Pyl’kevich ◽  
A. Dorokhova ◽  
...  
Keyword(s):  
Pulmonary Tuberculosis ◽  
Hiv Infection ◽  
Ocular Diseases

Oxidative Stress, Ocular Disease and Diabetes Retinopathy

2019 ◽  
Vol 24 (40) ◽  
pp. 4726-4741 ◽  
Author(s):  
Orathai Tangvarasittichai ◽  
Surapon Tangvarasittichai
Keyword(s):  
Oxidative Stress ◽  
Dna Damage ◽  
Cell Death ◽  
Protein Modification ◽  
Morphological Changes ◽  
Corneal Dystrophy ◽  
Age Related Macular Degeneration ◽  
Ocular Diseases ◽  
Retinal Light Damage ◽  
Age Related

Background: Oxidative stress is caused by free radicals or oxidant productions, including lipid peroxidation, protein modification, DNA damage and apoptosis or cell death and results in cellular degeneration and neurodegeneration from damage to macromolecules. Results: Accumulation of the DNA damage (8HOdG) products and the end products of LPO (including aldehyde, diene, triene conjugates and Schiff’s bases) were noted in the research studies. Significantly higher levels of these products in comparison with the controls were observed. Oxidative stress induced changes to ocular cells and tissues. Typical changes include ECM accumulation, cell dysfunction, cell death, advanced senescence, disarrangement or rearrangement of the cytoskeleton and released inflammatory cytokines. It is involved in ocular diseases, including keratoconus, Fuchs endothelial corneal dystrophy, and granular corneal dystrophy type 2, cataract, age-related macular degeneration, primary open-angle glaucoma, retinal light damage, and retinopathy of prematurity. These ocular diseases are the cause of irreversible blindness worldwide. Conclusions: Oxidative stress, inflammation and autophagy are implicated in biochemical and morphological changes in these ocular tissues. The development of therapy is a major target for the management care of these ocular diseases.

Bioadhesive glycosylated Nanoformulations for Extended Trans-Cornea Drug Delivery to Suppress Corneal Neovascularization

2021 ◽  
Author(s):  
Yanlong Zhang ◽  
Yunjian Yu ◽  
Gang Li ◽  
Xinge Zhang ◽  
Zhongming Wu ◽  
...  
Keyword(s):  
Drug Delivery ◽  
Corneal Epithelium ◽  
Corneal Neovascularization ◽  
Ocular Diseases ◽  
Rapid Clearance

Eye-drop formulations as conventional regiments to tackle ocular diseases are far from efficient due to the rapid clearance by eye tears and blockage of corneal epithelium barrier. Here, we describe...

scholarly journals A survey on computer aided diagnosis for ocular diseases

2014 ◽  
Vol 14 (1) ◽  
Author(s):  
Zhuo Zhang ◽  
Ruchir Srivastava ◽  
Huiying Liu ◽  
Xiangyu Chen ◽  
Lixin Duan ◽  
...  
Keyword(s):  
Computer Aided Diagnosis ◽  
Ocular Diseases ◽  
Computer Aided ◽  
Aided Diagnosis

Interleukin-6 participation in pathology of ocular diseases

2017 ◽  
Vol 24 (3) ◽  
pp. 123-131 ◽  
Author(s):  
Forouhe Zahir-Jouzdani ◽  
Fatemeh Atyabi ◽  
Nazanin Mojtabavi
Keyword(s):  
Interleukin 6 ◽  
Ocular Diseases

Development of novel drugs for ocular diseases: possibilities for individualized therapy

2010 ◽  
Vol 7 (4) ◽  
pp. 371-386
Author(s):  
Timothy YY Lai ◽  
Li Jia Chen ◽  
Gary HF Yam ◽  
Clement CY Tham ◽  
Chi Pui Pang
Keyword(s):  
Individualized Therapy ◽  
Ocular Diseases ◽  
Novel Drugs
Sign in / Sign up

Export Citation Format

Share Document